Your shopping cart is currently empty

m-PEG-NHS ester (MW 3400) can be used to modify active molecules, thereby enhancing their antigenicity and immunogenicity, which is beneficial for the preparation of injectable formulations. Its modification of serine protease lumbrokinase (LK) does not affect the enzyme’s strong fibrinolytic and thrombolytic activities, indicating promising application prospects.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | Inquiry | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 250 mg | Inquiry | Inquiry | Inquiry |
| Description | m-PEG-NHS ester (MW 3400) can be used to modify active molecules, thereby enhancing their antigenicity and immunogenicity, which is beneficial for the preparation of injectable formulations. Its modification of serine protease lumbrokinase (LK) does not affect the enzyme’s strong fibrinolytic and thrombolytic activities, indicating promising application prospects. |
| Synonyms | mPEG-Succinimidyl ester (MW 3400), mPEG-SC (MW 3400), m-PEG-NHS ester (MW 3400) |
| Molecular Weight | 3400(Average) |
| Formula | (C2H4O)nC7H9NO5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.